ArticleBMC infectious diseases2026
Impact of SARS-CoV-2 infection and viral burden on outcomes in acute decompensated heart failure.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesPatients hospitalized with acute decompensated heart failure (ADHF) represent a clinically vulnerable population. However, the impact of concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the prognostic relevance of viral burden in this setting remain incompletely understood.
methodsWe conducted a retrospective cohort study including 2,002 adults hospitalized with ADHF at a tertiary academic center between March 2020 and December 2024. SARS-CoV-2 infection was confirmed by reverse transcription quantitative polymerase chain reaction (RT-qPCR) during the index hospitalization. The primary outcome was in-hospital mortality. Secondary clinical outcomes were ICU admission and invasive mechanical ventilation, while hospital and ICU length of stay were assessed as resource-utilization outcomes. Multivariable regression models adjusted for clinically relevant covariates were used to assess associations between infection status and outcomes. Among infected patients, cycle threshold (Ct) values were analyzed as surrogate markers of viral burden.
resultsOf the 2,002 patients included, 246 (12.3%) had confirmed SARS-CoV-2 infection. Compared with uninfected patients, infected individuals had higher in-hospital mortality (32.5% vs. 20.6%), ICU admission (61.4% vs. 50.7%), and invasive mechanical ventilation (6.5% vs. 2.4%) (all p ≤ 0.002). After multivariable adjustment, SARS-CoV-2 infection remained associated with in-hospital mortality (aOR 2.63, p = 0.0002), ICU admission (aOR 1.79, p = 0.0027), and invasive mechanical ventilation (aOR 2.84, p = 0.0017). Infection was also associated with longer hospital stay (aβ + 9.23 days, p < 0.0001) and longer ICU stay (aβ + 7.85 days, p = 0.0017). Among infected patients, lower median Ct values were associated with higher in-hospital mortality (aOR 0.89 per Ct unit, p = 0.0338), while lower minimum Ct values were associated with longer hospital stay (adjusted β - 0.44 days per Ct unit, p = 0.0359).
conclusionsAmong patients hospitalized with ADHF, concomitant SARS-CoV-2 infection was associated with substantially worse in-hospital outcomes and greater healthcare resource utilization. The observed associations between lower Ct values and adverse in-hospital outcomes should be considered hypothesis-generating and require prospective validation because Ct values are imperfect surrogate markers of viral burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.